Pendal Group’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-132,147	Closed	-$955K	–	461
2019 Q1	$955K	Hold	132,147	–	–	0.01%	300
2018 Q4	$978K	Buy	+132,147	New	+$978K	0.02%	270